Cost Burden Analysis: To calculate the income burden faced in each state, we compared the average monthly out-of-pocket price of GLP-1 medications (pricing assumptions reflect a blended cash-pay range of approximately $150$450 per month, with $350 used as a common injectable reference point rather than a universal baseline) to each states per capita annual income
Weight loss during this phase is modest, typically 1 to 3% of body weight over four weeks
CR1, Complement Receptor type 1
GLP-1 Peptide Synthesis CDMO Market, Share & Trends Analysis Report, By Synthesis Technology (Solid-Phase Peptide Synthesis (SPPS), Liquid-Phase Peptide Synthesis (LPPS), Group-Assisted Purification Peptide Synthesis (GAP-PS), Hybrid Technology, Recombinant DNA Technology), By Service Type (Analytical and Process Development, Large-Scale Production, Custom Peptide Synthesis, Peptide Modification, Purification Technology, Formulation Development, Regulatory Support, Packaging and Labeling, Pre-Formulation and Registration Batches), By Scale of Operation, By End-User, By Region, and Segment Forecasts, 2025 to 2034
Ask your pharmacist for a list of the ingredients
